missing translation for 'onlineSavingsMsg'
Läs mer

Crenolanib, MedChemExpress

Produktkod. 16481727
Encompass_Preferred
Change view
Klicka för att se tillgängliga alternativ
Kvantitet:
5 mg
10 mg
50 mg
100 mg
Förpackningsstorlek:
10mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod. Kvantitet unitSize
16481727 50 mg -
16418267 5 mg -
16405568 10 mg 10mg
16466116 100 mg -
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 16481727 Leverantör Medchem Express Leverantörsnummer HY13223

Please to purchase this item. Need a web account? Register with us today!

Denna artikel kan inte returneras. Se returpolicy

MedChemExpress Crenolanib is a potent and selective inhibitor of wild-type and mutant isoforms of the class III receptor tyrosine kinases FLT3 and PDGFRα/β with Kds of 0.74 nM and 2.1 nM/3.2 nM, respectively.

Crenolanib is a potent and selective inhibitor of wild-type and mutant isoforms of the class III receptor tyrosine kinases FLT3 and PDGFRα/β with Kds of 0.74 nM and 2.1 nM/3.2 nM, respectively.

Specifications

Kemiskt namn eller material Crenolanib
CAS 670220-88-9
Färg Off-White
Anteckningar om renhetsgrad Research
Molekylformel C26H29N5O2
Kvantitet 50 mg
Synonym CP-868596
Löslighetsinformation DMSO : 25 mg/mL (56.36 mM; ultrasonic and warming and heat to 60°C)
LEDER NC1CCN(C2=CC=CC3=C2N=C(N4C5=CC=C(C=C5N=C4)OCC6(COC6)C)C=C3)CC1
Molekylvikt (g/mol) 443.54
Formel vikt 443.54
Procent renhet 99.5%
Kvalitet Research
Fysisk form Powder
För användning med (applikation) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.